Background-Activation of the sympathetic nervous system has been extensively studied in patients with chronic heart failure, but the parasympathetic nervous system has received relatively little attention. The objective in this study was to investigate cardiac parasympathetic activity in chronic heart failure and to explore its relation to left ventricular function.
waking 48 (1-275)/h, sleeping 62 (0-360)/ h, and total 1310 (31-7278)/24 h. These were lower than expected, and in 26 (60%) of the 43 patients counts fell below the lower 95% confidence intervals (95% CI) for RR counts in normal subjects. A significant correlation between total 24 hour RR counts and left ventricular ejection fraction was present (r = 0 49, p < 005).
Conclusions-These results indicate that most patients with chronic heart failure have reduced heart rate variability and therefore reduced cardiac parasympathetic activity. The degree of parasympathetic dysfunction is related to the severity of left ventricular dysfunction. This may be relevant to the high incidence of ventricular arrhythmias and poor prognosis of patients with chronic heart failure.
Unlike most other diseases of the cardiovascular system, the incidence and prevalence of chronic heart failure is rising in the Western world.'2 Chronic heart failure is therefore an increasing cause of disability and death in the community.
Autonomic control of the cardiovascular system is deranged in chronic heart failure and contributes to the pathophysiology of the syndrome.' The sympathetic nervous system has been widely studied and its activity is enhanced in chronic heart failure. 4 The amount of sympathetic activation is linked to symptoms5 and haemodynamic indices of impaired left ventricular function.67 Although the sympathetic nervous system is activated in chronic heart failure, reflex changes in autonomic activity during stress are impaired.89
Increasing sympathetic activation is associated with a progressive rise in afterload leading to a deterioration in myocardial pump function7 10 11 and has an inverse relation with survival.'2 Although abnormal parasympathetic function has also been found in chronic heart failure, this has not been extensively studied.3 14 Analysis of variability of heart rate has been developed over the last decade as a useful non-invasive way of measuring activity of the autonomic nervous system. We have developed a method, with 24 hour electrocardiograms, that is a reliable and a specific index of cardiac parasympathetic function, '5 and is valid even in the presence of frequent ventricular extrasystoles. '6 Our aims in this study were to determine whether abnormal cardiac parasympathetic activity is present in patients with chronic heart failure and to examine the relation between resting left ventricular function and cardiac parasympathetic function.
Patients and methods

PATIENTS WITH CHRONIC HEART FAILURE
Sixty ambulatory patients (42 men) with chronic heart failure due to ischaemic heart disease were studied. activation is proportional to the clinical severity of the heart failure.38 Angiotensin II is * known to interact both centrally and peripherally with the autonomic nervous system to enhance sympathetic39 ' and inhibit parasympathetic activity.4142 Increasing neuro-20 2I5 30 35 endocrine activation in patients with chronic 20 25 30 35 heart failure may therefore explain the -ft ventricular ejectionr presence of parasympathetic impairment and ction (M) its relation to impaired left ventricular function. An alternative or additional mechanism in RATE VARIABILITY patients with ischaemic heart disease could be ICTION direct injury to intracardiac nerves and recepcn between total 24 tors, leading to disruption of autonomic ventricular ejection reflexes. We have previously shown that tear correlation was parasympathetic impairment occurs early in 20 ints obtained in the the course of anterior myocardial infarction. impairment of left As chronic heart failure is more likely to occur ).49, p < 0.05).
after anterior than inferior infarction, this lends support to direct damage as a possible mechanism for original parasympathetic impairment in these patients, with increasing neuroendocrine activation contributing to idy that most of our progressive changes in those patients whose left eart failure due to ventricular function declines with time. ve reduced heart rate Sudden death occurs in almost 50% of e, therefore, reduced patients with chronic heart failure.243 Auto--tivity. Also, we have nomic imbalance is known to be linked to the lation exists between production of ventricular arrhythmias that are alar dysfunction and thought to be the cause of sudden death in most athetic impairment. patients with chronic heart failure."4 The lumber of potential reduction of parasympathetic activity that we have shown to occur in the presence of symshown that sym-pathetic overactivity, may therefore provide -s in chronic heart suitable conditions for the production of ensatory mechanism ventricular arrhythmias. We have already ral blood pressure.3' investigated the role of the angiotensin conrmpathetic nervous verting enzyme inhibitor captopril in ogy and prognosis of regulating parasympathetic activity in chronic not been studied in heart failure.47 Captopril is known to have a udies of heart rate beneficial effect on the incidence of ventricular rt failure, one using arrhythmias' and sudden death in chronic 2 and the other a heart failure.49 The increase in parasympathetic lof analysis,33 show a activity that we demonstrated along with the heart rate variability reduction in sympathetic activity that is known Lrawbacks. Standard to occur with captopril treatment, may be clearly differentiate relevant to these effects. id parasympathetic
We have also studied the effect of class I and Lanalysis, unlike our class III antiarrhythmic drugs, commonly used iable in the presence in the treatment of ventricular arrhythmias in oles, which occur patients with chronic heart failure.'6 Some class with chronic heart I agents reduce cardiac parasympathetic cific as a measure of activity and this may be an important factor in and clearly shows the adverse effect on prognosis that can occur sympathetic activity when class I agents are used to treat ventricular iour period. '5 16192028 arrhythmias in patients with impaired ular function and the ventricular function.50 By contrast, the class III tivation are linked to agent amiodarone does not reduce cardiac vith chronic heart parasympathetic activity. This may explain i severe impairment why this.agent does not have an adverse effect5' tion have maximal and may improve survival52 when used to treat ventricular arrhythmias in chronic heart failure.
In conclusion, we have shown that cardiac parasympathetic activity is reduced in most patients with chronic heart failure and that the magnitude of this reduction is correlated with the severity of left ventricular impairment. Reduced heart rate variability is a powerful independent risk factor for sudden death in survivors ofmyocardial infarction.53 Long term follow up studies of patients with chronic heart failure are now needed to find out whether reduced heart rate variability will have a similar predictive value in these patients.
